Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/19/2021 38 37
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 28 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/04/2020 17 6
Nilotinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/24/2020 3 0
4-{[5-(2-Nitrophenyl)-2-furyl] methylene}-3-phenyl-5(4H)-isoxazolone Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020 1 0
4-Chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020 1 0